Inspire Medical Systems (INSP) EV to EBITDA (2018 - 2026)

Inspire Medical Systems has disclosed EV to EBITDA across 9 years of filings, most recently posting 1884.96 for Q2 2026.

• In Q2 2026, EV to EBITDA fell 76.75% year-over-year to 1884.96; the TTM figure through Jun 2026 stood at 17.9 (down 79.04% YoY), while the FY2025 annual figure was 45.68, down 67.47% from the prior year.
• EV to EBITDA came in at 1884.96 for Q2 2026 at Inspire Medical Systems, down from 1074.93 in the prior quarter.
• In the past five years, EV to EBITDA ranged from a high of 696.05 in Q2 2024 to a low of 20463.33 in Q4 2022.
• Average EV to EBITDA over 5 years is 1555.76, with a median of 368.11 recorded in 2024.
• Year-over-year, EV to EBITDA soared 227.62% in 2024 and tumbled 646.96% in 2025.
• Over 5 years, EV to EBITDA stood at 20463.33 in 2022, then soared by 102.92% to 597.3 in 2023, then sank by 73.39% to 158.94 in 2024, then sank by 68.24% to 50.48 in 2025, then slumped by 3834.24% to 1884.96 in 2026.
• Per Business Quant data, the three most recent EV to EBITDA figures were 1884.96 in Q2 2026, 1074.93 in Q1 2026, and 50.48 in Q4 2025.